Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05061134
Title A Study of Ceralasertib Monotherapy and Ceralasertib Plus Durvalumab in Patients With Melanoma and Resistance to PD-(L)1 Inhibition (MONETTE)
Acronym MONETTE
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | GBR | FRA | ESP | DEU | CAN | BEL | AUS

Facility Status City State Zip Country Details
Research Site Los Angeles California 90024 United States Details
Research Site Sacramento California 95816 United States Details
Research Site San Francisco California 94143 United States Details
Research Site Tampa Florida 33612 United States Details
Research Site Lutherville-Timonium Maryland 21093 United States Details
Research Site Nashville Tennessee 37232 United States Details
Research Site East Melbourne 3002 Australia Details
Research Site Herston 4029 Australia Details
Research Site Woolloongabba 4102 Australia Details
Research Site Belgium 1200 Belgium Details
Research Site Gent 9000 Belgium Details
Research Site Leuven 3000 Belgium Details
Research Site Edmonton Alberta t6G1Z2 Canada Details
Research Site London Ontario N6A 4G5 Canada Details
Research Site Toronto Ontario M4N 3M5 Canada Details
Research Site Toronto Ontario M5G 2M9 Canada Details
Research Site Ste-Foy Quebec G1V 4G2 Canada Details
Research Site Bobigny 93009 France Details
Research Site Boulogne Billancourt 92100 France Details
Research Site Marseille Cedex 5 13385 France Details
Research Site Paris 75010 France Details
Research Site Pau Cedex 64046 France Details
Research Site Pierre Benite Cedex 69310 France Details
Research Site Poitiers 86021 France Details
Research Site Vandoeuvre-Les-Nancy 54511 France Details
Research Site Villejuif Cedex 94805 France Details
Research Site Berlin 10117 Germany Details
Research Site Buxtehude 21614 Germany Details
Research Site Heidelberg 69120 Germany Details
Research Site Heilbronn 74078 Germany Details
Research Site Kiel 24105 Germany Details
Research Site Mainz 55131 Germany Details
Research Site München 80337 Germany Details
Research Site Regensburg 93053 Germany Details
Research Site Schwerin 19049 Germany Details
Research Site Tuebingen D-72076 Germany Details
Research Site Candiolo 10060 Italy Details
Research Site Milan 20141 Italy Details
Research Site Napoli 80131 Italy Details
Research Site Padova 35128 Italy Details
Research Site Perugia 06156 Italy Details
Research Site Roma 00168 Italy Details
Research Site Siena 53100 Italy Details
Research Site Goyang 410-769 Korea, Republic of Details
Research Site Seoul 03722 Korea, Republic of Details
Research Site Seoul 05505 Korea, Republic of Details
Research Site Seoul 06351 Korea, Republic of Details
Research Site Brzozów 36-200 Poland Details
Research Site Gdańsk 80-214 Poland Details
Research Site Kraków 31-115 Poland Details
Research Site Lodz 93-513 Poland Details
Research Site Poznan 60-355 Poland Details
Research Site Warszawa 02-781 Poland Details
Research Site Barcelona 08041 Spain Details
Research Site Madrid 28007 Spain Details
Research Site Madrid 28027 Spain Details
Research Site Madrid 28034 Spain Details
Research Site Madrid 28040 Spain Details
Research Site Málaga 29009 Spain Details
Research Site Pozuelo de Alarcon 28223 Spain Details
Research Site Cambridge CB2 0QQ United Kingdom Details
Research Site Chelsea SW3 6JJ United Kingdom Details
Research Site Manchester M20 4BX United Kingdom Details
Research Site Northwood HA6 2RN United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field